NCT04300569View on ClinicalTrials.gov

A Study to Determine the Signs and Symptoms That Impact Daily Life of Participants With Irregular Sleep-Wake Rhythm Disorder

CompletedOBSERVATIONAL
Enrollment

37

Participants

Timeline

Start Date

July 9, 2020

Primary Completion Date

September 7, 2020

Study Completion Date

September 7, 2020

Conditions
Irregular Sleep Wake Rhythm Disorder
Interventions
OTHER

Non-interventional

No intervention will be administered.

Trial Locations (6)

19090

Abington Neurologic Associate, Willow Grove

30331

Atlanta Center for Medical Research, Atlanta

33014

Panax Clinical Research, Miami Lakes

33137

Miami Jewish Health Systems, Miami

92103

Pacific Research Network Inc, San Diego

92626

ATP Clinical Research, Costa Mesa

All Listed Sponsors
lead

Eisai Inc.

INDUSTRY

NCT04300569 - A Study to Determine the Signs and Symptoms That Impact Daily Life of Participants With Irregular Sleep-Wake Rhythm Disorder | Biotech Hunter | Biotech Hunter